Travere Therapeutics (TVTX) Other Non-Current Liabilities (2011 - 2026)
Travere Therapeutics (TVTX) reported Other Non-Current Liabilities of $12.07 million for Q2 2026, up 53.1% from $7.88 million a year earlier and up 28.7% from the prior quarter.
Travere Therapeutics (TVTX) Other Non-Current Liabilities (2011 - 2026) Analysis & Trends
At the end of FY2025, Travere Therapeutics posted Other Non-Current Liabilities of $7.6 million, up 11.8% from FY2024.
- Other Non-Current Liabilities has a five-year compound annual growth rate of -34.9% (FY2020 to FY2025).
- By year, Other Non-Current Liabilities came in at $6.8 million in FY2024 (-34.1%), $10.32 million in FY2023 (+10.0%), $9.39 million in FY2022 (-86.0%) and $67.1 million in FY2021 (+3.1%).
- The Q2 2026 figure ranks as the highest quarterly Other Non-Current Liabilities since Q3 2024.
- Year over year, Other Non-Current Liabilities has now increased in each of the last three quarters, with an average decline of 2.2% over the last eight quarters.
- The high point for year-over-year Other Non-Current Liabilities in five years was Q3 2024 (growth of 94.3%); the low point was Q3 2023 (a decline of 89.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $9.38 million (Q1 2026), $7.6 million (Q4 2025) and $5.93 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Travere Therapeutics | 5.55 Bn | 5.14 Bn | 167.41 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.07 Mn |
| Mar 31, 2026 | 9.38 Mn |
| Dec 31, 2025 | 7.60 Mn |
| Sep 30, 2025 | 5.93 Mn |
| Jun 30, 2025 | 7.88 Mn |
| Mar 31, 2025 | 7.27 Mn |
| Dec 31, 2024 | 6.80 Mn |
| Sep 30, 2024 | 16.29 Mn |
| Jun 30, 2024 | 16.64 Mn |
| Mar 31, 2024 | 16.38 Mn |
| Dec 31, 2023 | 10.32 Mn |
| Sep 30, 2023 | 8.38 Mn |
| Jun 30, 2023 | 74.10 Mn |
| Mar 31, 2023 | 75.20 Mn |
| Dec 31, 2022 | 9.39 Mn |
| Sep 30, 2022 | 76.20 Mn |
| Jun 30, 2022 | 75.70 Mn |
| Mar 31, 2022 | 73.50 Mn |
| Dec 31, 2021 | 67.10 Mn |
| Sep 30, 2021 | 43.26 Mn |
Travere Therapeutics Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=TVTX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "TVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=TVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();